Loading
Latest filing published 05 Oct 2015 for Medite Cancer Diagnostics, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Michael Egbert Ott discloses dealings in Medite Cancer Diagnostics, Inc. to SEC (Form 4). The record holds 2 filings, all for trades on 5 October 2015.
The open-market record is one-sided, with 2 purchases and not one sale. The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 5 October 2015 came the latest disclosure, an open-market purchase in Medite Cancer Diagnostics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations